Epoxyeicosatrienoic acids mediate adenosine-induced vasodilation in rat preglomerular microvessels (PGMV) via A 2A receptors

British Journal of Pharmacology

Volumn 141, Issue 3, 2004, Pages 441-448

  Cheng, M K ^a   Doumad, A B ^a   Jiang, H ^a   Falck, J R ^b   McGiff, J C ^a   Carroll, M A ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

A 1 receptors; A 2A receptors; Adenosine; Cytochrome P450; Rat renal artery; Renal EETs

Indexed keywords

11,12 EPOXY 5,8,14 ICOSATRIENOIC ACID; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 5,6 EPOXY 8,11,14 ICOSATRIENOIC ACID; 8,9 EPOXYICOSATRIENOIC ACID; ADENOSINE A2 RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; COMPLEMENT COMPONENT C1S; EPOXYICOSATRIENOIC ACID; HYDROXYICOSATETRAENOIC ACID; INDOMETACIN; MESYLIC ACID DERIVATIVE; METHYLSULFONYLPROPARGYLOXYPHENYLHEXANAMIDE; NITRIC OXIDE; PHENYLEPHRINE; PROSTAGLANDIN SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTERY TONE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; GLOMERULUS CAPILLARY; LIGATION; MALE; MICROVASCULATURE; NONHUMAN; PREGLOMERULAR MICROVESSEL; PRIORITY JOURNAL; RAT; VASODILATATION;

8,11,14-EICOSATRIENOIC ACID; ADENOSINE; ANIMALS; ARACHIDONIC ACIDS; CYTOCHROME P-450 ENZYME SYSTEM; EPOXY COMPOUNDS; GLOMERULAR MESANGIUM; MALE; MICROCIRCULATION; OXYGENASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; RENAL ARTERY; VASODILATION;

EID: 1542329729     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705640     Document Type: Article

References (51)

1. ABEBE, W., MAKUJINA, S.R. & MUSTAFA, S.J. (1994). Adenosine receptor-mediated relaxation of porcine coronary artery in presence and absence of endothelium. Am. J. Physiol., 266, H2018-H2025.
2. AKI, Y., NISHIYAMA, A., MIYATAKE, A., KIMURA, S., KOHNO, M. & ABE, Y. (2002). Role of adenosine A(1) receptor in angiotensin II-and norepinephrine-induced renal vasoconstriction. J. Pharmacol. Exp. Ther., 303, 117-123.
3. BERNE, R.M. (1980). The role of adenosine in the regulation of coronary blood flow. Circ. Res., 47, 807-813.
4. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
5. BRAND-SCHIEBER, E., FALCK, J.F. & SCHWARTZMAN, M. (2000). Selective inhibition of arachidonic acid epoxidation in vivo. J. Physiol. Pharmacol., 51, 655-672.
6. BROWN, R., OLLERSTAM, A., JOHANSSON, B., SKOTT, O., GEBRE-MEDHIN, S., FREDHOLM, B. & PERSSON, A.E. (2001). Abolished tubuloglomerular feedback and increased plasma renin in adenosine A1 receptor-deficient mice. Am. J. Physiol. Regul. Integr. Comp. Physiol., 281, R1362-R1367.
7. BURNSTOCK, G. (1980). Purinergic receptors in the heart. Circ. Res., 46, I175-I182.
8. CAMPBELL, W.B., GEBREMEDHIN, D., PRATT, P.F. & HARDER, D.R. (1996). Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res., 78, 415-423.
9. CARROLL, M.A., BALAZY, M., MARGIOTTA, P., HUANG, D.D., FALCK, J.R. & MCGIFF, J.C. (1996). Cytochrome P-450-dependent HETEs: profile of biological activity and stimulation by vasoactive peptides. Am. J. Physiol., 271, R863-R869.
10. CARROLL, M.A., GARCIA, M.P., FALCK, J.R. & MCGIFF, J.C. (1990). 5,6-epoxyeicosatrienoic acid, a novel arachidonate metabolite. Mechanism of vasoactivity in the rat. Circ. Res., 67, 1082-1088.
11. CARROLL, M.A., GARCIA, M.P., FALCK, J.R. & MCGIFF, J.C. (1992). Cyclooxygenase dependency of the renovascular actions of cytochrome P450-derived arachidonate metabolites. J. Pharmacol. Exp. Ther., 260, 104-109.
12. CHATZIANTONIOU, C. & ARENDSHORST, W.J. (1993). Angiotensin receptor sites in renal vasculature of rats developing genetic hypertension. Am. J. Physiol., 265, F853-F862.
13. CHENG, M.K., MCGIFF, J.C. & CARROLL, M.A. (2003). Renal arterial 20-hydroxyeicosatetraenoic acid levels: regulation by cyclooxygenase. Am. J. Physiol. Renal Physiol., 284, F474-F479.
14. CROFT, K.D., MCGIFF, J.C., SANCHEZ-MENDOZA, A. & CARROLL, M.A. (2000). Angiotensin II releases 20-HETE from rat renal microvessels. Am. J. Physiol. Renal Physiol., 279, F544-F551.
15. DUBEY, R.K., GILLESPIE, D.G., OSAKA, K., SUZUKI, F. & JACKSON, E.K. (1996). Adenosine inhibits growth of rat aortic smooth muscle cells. Possible role of A2b receptor. Hypertension, 27, 786-793.
16. DUMOULIN, M., SALVAIL, D., GAUDREAULT, S.B., CADIEUX, A. & ROUSSEAU, E. (1998). Epoxyeicosatrienoic acids relax airway smooth muscles and directly activate reconstituted KCa channels. Am. J. Physiol., 275, L423-L431.
17. FISSLTHALER, B., POPP, R., KISS, L., POTENTE, M., HARDER, D.R., FLEMING, I. & BUSSE, R. (1999). Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature, 401, 493-497.
18. FULTON, D., FALCK, J.R., MCGIFF, J.C., CARROLL, M.A. & QUILLEY, J. (1998). A method for the determination of 5,6-EET using the lactone as an intermediate in the formation of the diol. J. Lipid Res., 39, 1713-1721.
19. FULTON, D., MCGIFF, J.C. & QUILLEY, J. (1992). Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney. Br. J. Pharmacol., 107, 722-725.
20. GUYTON, A.C. & COLEMAN, T.G. (1969). Quantitative analysis of the pathophysiology of hypertension. Circ. Res., 24, 1-19.
21. HARDER, D.R., NARAYANAN, J., BIRKS, E.K., LIARD, J.F., IMIG, J.D., LOMBARD, J.H., LANGE, A.R. & ROMAN, R.J. (1996). Identification of a putative microvascular oxygen sensor. Circ. Res., 79, 54-61.
22. HEIN, T.W., BELARDINELLI, L. & KUO, L. (1999). Adenosine A(2A) receptors mediate coronary microvascular dilation to adenosine: role of nitric oxide and ATP-sensitive potassium channels. J. Pharmacol. Exp. Ther., 291, 655-664.
23. HERCULE, H.C. & OYEKAN, A.O. (2000a). Cytochrome P450 omega/omega-1 hydroxylase-derived eicosanoids contribute to endothelin(A) and endothelin(B) receptor-mediated vasoconstriction to endothelin-1 in the rat preglomerular arteriole. J. Pharmacol. Exp. Ther., 292, 1153-1160.
24. HERCULE, H.C. & OYEKAN, A.O. (2000b). Role of NO and cytochrome P-450-derived eicosanoids in ET-1-induced changes in intrarenal hemodynamics in rats. Am. J. Physiol Regul. Integr. Comp. Physiol., 279, R2132-R2141.
25. HOLZ, F.G. & STEINHAUSEN, M. (1987). Renovascular effects of adenosine receptor agonists. Renal Physiol., 10, 272-282.
26. IMIG, J.D., FALCK, J.R., WEI, S. & CAPDEVILA, J.H. (2001). Epoxygenase metabolites contribute to nitric oxide-independent afferent arteriolar vasodilation in response to bradykinin. J. Vasc. Res., 38, 247-255.
27. IMIG, J.D., NAVAR, L.G., ROMAN, R.J., REDDY, K.K. & FALCK, J.R. (1996a). Actions of epoxygenase metabolites on the preglomerular vasculature. J. Am. Soc. Nephrol., 7, 2364-2370.
28. IMIG, J.D., ZOU, A.P., STEC, D.E., HARDER, D.R., FALCK, J.R. & ROMAN, R.J. (1996b). Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am. J. Physiol., 270, R217-R227.
29. INSCHO, E.W., CARMINES, P.K. & NAVAR, L.G. (1991). Juxtamedullary afferent arteriolar responses to P1 and P2 purinergic stimulation. Hypertension, 17, 1033-1037.
30. JACKSON, E.K. & DUBEY, R.K. (2001). Role of the extracellular cAMP-adenosine pathway in renal physiology. Am. J. Physiol. Renal Physiol., 281, F597-F612.
31. JACKSON, E.K., ZHU, C. & TOFOVIC, S.P. (2002). Expression of adenosine receptors in the preglomerular microcirculation. Am. J. Physiol Renal Physiol., 283, F41-F51.
32. KARARA, A., DISHMAN, E., FALCK, J.R. & CAPDEVILA, J.H. (1991). Endogenous epoxyeicosatrienoyl-phospholipids. A novel class of cellular glycerolipids containing epoxidized arachidonate moieties. J. Biol. Chem., 266, 7561-7569.
33. KAUSER, K., CLARK, J.E., MASTERS, B.S., ORTIZ DE MONTELLANO, P.R., MA, Y.H., HARDER, D.R. & ROMAN, R.J. (1991). Inhibitors of cytochrome P-450 attenuate the myogenic response of dog renal arcuate arteries. Circ. Res., 68, 1154-1163.
34. LEDENT, C., VAUGEOIS, J.M., SCHIFFMANN, S.N., PEDRAZZINI, T., EL YACOUBI, M., VANDERHAEGHEN, J.J., COSTENTIN, J., HEATH, J.K., VASSART, G. & PARMENTIER, M. (1997). Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature, 388, 674-678.
35. LEVENS, N., BEIL, M. & JARVIS, M. (1991). Renal actions of a new adenosine agonist, CGS 21680A selective for the A2 receptor. J. Pharmacol. Exp. Ther., 257, 1005-1012.
36. LEWIS, C.D., HOURANI, S.M., LONG, C.J. & COLLIS, M.G. (1994). Characterization of adenosine receptors in the rat isolated aorta. Gen. Pharmacol., 25, 1381-1387.
37. MACICA, C., BALAZY, M., FALCK, J.R., MIOSKOWSKI, C. & CARROLL, M.A. (1993). Characterization of cytochrome P-450-dependent arachidonic acid metabolism in rabbit intestine. Am. J. Physiol., 265, G735-G741.
38. MARTIN, P.L. & POTTS, A.A. (1994). The endothelium of the rat renal artery plays an obligatory role in A2 adenosine receptor-mediated relaxation induced by 5′-N-ethylcarboxamidoadenosine and N6-cyclopentyladenosine. J. Pharmacol. Exp. Ther., 270, 893-899.
39. MUNGER, K.A. & JACKSON, E.K. (1994). Effects of selective A1 receptor blockade on glomerular hemodynamics: involvement of renin-angiotensin system. Am. J. Physiol., 267, F783-F790.
40. NAVAR, L.G. (1998). Integrating multiple paracrine regulators of renal microvascular dynamics. Am. J. Physiol., 274, F433-F444.
41. NAVAR, L.G., GUYTON, A.C. & LANGSTON, J.B. (1966). Effect of alterations in plasma osmolality on renal blood flow autoregulation. Am. J. Physiol., 211, 1387-1392.
42. NAVAR, L.G., INSCHO, E.W., MAJID, S.A., IMIG, J.D., HARRISON-BERNARD, L.M. & MITCHELL, K.D. (1996). Paracrine regulation of the renal microcirculation. Physiol. Rev., 76, 425-536.
43. NISHIYAMA, A., INSCHO, E.W. & NAVAR, L.G. (2001). Interactions of adenosine A1 and A2a receptors on renal microvascular reactivity. Am. J. Physiol. Renal Physiol., 280, F406-F414.
44. OLAH, M.E. & STILES, G.L. (2000). The role of receptor structure in determining adenosine receptor activity. Pharmacol. Ther., 85, 55-75.
45. OYEKAN, A.O., YOUSEFF, T., FULTON, D., QUILLEY, J. & MCGIFF, J.C. (1999). Renal cytochrome P450 omega-hydroxylase and epoxygenase activity are differentially modified by nitric oxide and sodium chloride. J. Clin. Invest., 104, I131-I137.
46. POUCHER, S.M., KEDDIE, J.R., SINGH, P., STOGGALL, S.M., CAULKETT, P.W., JONES, G. & COLL, M.G. (1995). The in vitro pharmacology of ZM 241385, a potent, non-xanthine A2a selective adenosine receptor antagonist. Br. J. Pharmacol., 115, 1096-1102.
47. + channels in A2A adenosine receptor-mediated dilation of the pressurized renal arcuate artery. Br. J. Pharmacol., 126, 494-500.
48. RUMP, L.C., JABBARI-T, J., VON KUGELGEN, I. & OBERHAUSER, V. (1999). Adenosine mediates nitric-oxide-independent renal vasodilation by activation of A2A receptors. J. Hypertens., 17, 1987-1993.
49. SUN, D., SAMUELSON, L.C., YANG, T., HUANG, Y., PALIEGE, A., SAUNDERS, T., BRIGGS, J. & SCHNERMANN, J. (2001). Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors. Proc. Natl. Acad. Sci. U.S.A., 98, 9983-9988.
50. ZHAO, X., INSCHO, E.W., BONDLELA, M., FALCK, J.R. & IMIG, J.D. (2001). The CYP450 hydroxylase pathway contributes to P2X receptor-mediated afferent arteriolar vasoconstriction. Am. J. Physiol. Heart Circ. Physiol., 281, H2089-H2096.
51. ZOU, A.P., NITHIPATIKOM, K., LI, P.L. & COWLEY JR., A.W. (1999). Role of renal medullary adenosine in the control of blood flow and sodium excretion. Am. J. Physiol., 276, R790-R798.